Please login to the form below
Crucell
This page shows the latest Crucell news and features for those working in and with pharma, biotech and healthcare.
Janssen’s quest to prevent diseases taking hold
Janssen’s acquisition of Crucell in 2011 brought it a suite of promising platforms covering HIV, a universal flu vaccine, respiratory syncytial virus (RSV), which is an infection of the lungs
Latest news
-
Ebola vaccine halt 'a precaution' say researchers
Meanwhile, Johnson &Johnson (J&J) is also stepping up production of its own candidate - being developed by subsidiary Crucell in partnership with the Danish biotech Bavarian Nordic and the US National
-
J&J to produce one million doses of Ebola vaccine
The vaccine is being developed by J&J's Netherlands-based subsidiary Crucell in partnership with the Danish biotech Bavarian Nordic and the US National Institutes of Health (NIH). ... It combines Crucell's AdVac technology and Bavarian Nordi's MVA-BN
-
J&J fast-tracks Ebola vaccine
The US-based healthcare giant's subsidiary Crucell – based in the Netherlands – is collaborating with the Danish biotech Bavarian Nordic on a combination vaccine regimen with clinical trials in humans planned ... So far the regimen – which combines
-
Chugai appoints US CMO
At Merck Serono he served as head of clinical development for small molecules in onco-haematology and his prior experience includes clinical roles across Europe at Novartis, Crucell, Bavarian Nordic and
-
Janssen boosts vaccines pipeline with GlycoVaxyn deal
Its early development will see GlycoVaxyn collaborate with Janssen's vaccines- focused affiliate Crucell, but once the programme enters later-stage clinical studies, Janssen will take over development and then lead
More from news
Approximately 1 fully matching, plus 23 partially matching documents found.
Latest appointments
-
Kiadis Pharma appoints new chief operations officer
Prior to his time at Janssen, Feijen held positions for the likes of Crucell, Avebe and Gist Brocades.
-
Cell Medica adds to senior management team
He brings extensive experience in biotechnology manufacturing to the role, having held senior leadership positions at Crucell, Merck, Roche and Schering-Plough.
-
TiGenix appoints Dr Marie Paule Richard
TiGenix appoints Dr Marie Paule Richard. She takes on role as chief medical officer and brings experience from Aicuris and Crucell. ... pharmacovigilance and medical affairs at Crucell in Switzerland.
More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.
Featured jobs
-
Senior Account Manager - Med Comms
-
Highly Competitive Salary &Benefits
-
Account Director - Digital
-
Great salary and benefits
- Account Director – Global Healthcare PR
-
Salary TBC
-
Scientific Director
-
Highly Competitive Salary &Benefits
-
Scientific Team Lead
-
Competitive Salary
- Director Healthcare PR Communications
-
Salary TBC
- Experienced Editor, London, Medical Communications
-
Competitive package
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 benefits
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Lead Medical Copywriter, Healthcare Brand Communications, London
-
Excellent package
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
-
Associate Medical Director
-
Salary TBC
- Account Manager, Healthcare Advertising
-
Salary TBC
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
- Senior Account Manager / Account Director - Med Comms
-
Great salary and benefits
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
Subscribe to our email news alerts
PMHub
Havas Life Medicom
We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...
Latest intelligence
- Making Europe a leader in bioscience: boosting trust and opening minds
- A vision of Paris as Europe’s leading hub for life sciences innovation...
- Tackling a formidable foe
- Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
- Cancer care – the power of new technologies
- With patient numbers set to soar, how can we make a difference?...
Quick links
Infographics
